<DOC>
	<DOCNO>NCT00143286</DOCNO>
	<brief_summary>The primary purpose study comparison abstinence maintenance subject randomize double-blind varenicline placebo Weeks 13 -24 subject respond intial 12-week open label course varenicline , post-treatment follow-up smoking status Week 52 .</brief_summary>
	<brief_title>A 52-Week Multicenter Study Evaluating Safety Efficacy Varenicline Maintenance Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Subjects must smoke average least 10 cigarette per day past year month prior screen visit , period abstinence great 3 month past year . Subjects clinically significant cardiovascular disease past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>